For citations:
Loshkova E.V., Doroshenko I.V., Liulka T.S., Khavkin A.I., Kondratieva E.I., Odinaeva N.D., Rafikova Yu.S., Zhelev V.A., Solnyshko A.L., Mikhalev E.V., Ermolenko S.P., Grishkevich I.R., Melnikov N.E., Bohunetsky A.A., Makarevich E.I. Pathophysiological mechanisms and clinical consequences of exposure to new psychoactive substances (“salts”) on a newborn. Pediatric pharmacology. 2023;20(6):546–556. (In Russ.) https://doi.org/10.15690/pf.v20i6.2703
Email this article 